Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2020 07:00 ET | Source: Guardion Health Sciences, Inc.

Guardion Health Sciences Reports First Quarter 2020 Financial Results and Provides Corporate Update

— 40% increase in medical foods revenue in the first quarter compared to the same period last year — Launch of immuno-supportive/antioxidant complex, acuMMUNE™ — Growing portfolio of synergistic...
May 12, 2020 07:05 ET | Source: Guardion Health Sciences, Inc.

Lumega-Z® Demonstrates Superiority in a Head-to-Head Study Showing Better Bioavailability of Carotenoids and Restoring Macular Pigment Density

-- First study to provide a head-to-head comparison of two commercially available supplements with regard to the changes in serum levels of carotenoids, visual function and macular pigment optical...
April 15, 2020 09:05 ET | Source: Guardion Health Sciences, Inc.

Guardion Health Sciences to Present at the April 2020 Virtual Investor Summit

– Presentation with live audio webcast on Wednesday, April 22 at 1:30 PM ET, immediately followed by an interactive Q&A session – San Diego, California, April 15, 2020 (GLOBE NEWSWIRE)...
April 14, 2020 11:00 ET | Source: Guardion Health Sciences, Inc.

Guardion Health Sciences Announces Launch of acuMMUNE: An Immuno-Supportive/Anti-Oxidant Complex

- acuMMUNE now available for sale in the United States through online platforms - San Diego, California, April 14, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the...
April 01, 2020 07:00 ET | Source: Guardion Health Sciences, Inc.

Guardion Health Sciences Receives Initial Order from Malaysian Company for Exclusive Immuno-Supportive Formula

--Initial order for $875,000 from Astramune Sdn Bhd, a subsidiary of Ho Wah Genting Berhad --Formula designed to provide immune-supportive benefits --Formula developed by the Company’s...
March 30, 2020 09:00 ET | Source: Guardion Health Sciences, Inc.

Guardion Health Sciences Reports 2019 Year End Results and Provides Corporate Update and Overview

--Growing portfolio of synergistic assets and proprietary technologies --Focusing on scalable market opportunities to drive Company’s growth initiatives --Maintaining vision...
March 19, 2020 12:05 ET | Source: Guardion Health Sciences, Inc.

Guardion Health Sciences Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule

- No immediate effect on the Company’s Nasdaq listing or the trading of its common stock - San Diego, California, March 19, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or...
March 06, 2020 08:05 ET | Source: Guardion Health Sciences, Inc.

Guardion Health Sciences Receives $3.5 Million from Exercise of Warrants

San Diego, California, March 06, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), an ocular health sciences company that develops, formulates,...
February 26, 2020 07:00 ET | Source: Guardion Health Sciences, Inc.

Guardion Health Sciences Selected by Malaysian Listed Company to Develop an Immuno-Supportive Formula

Guardion® has signed a Letter of Appointment with Ho Wah Genting Berhad (HWGB) to create a new formula, designed to enhance the immune system.The formula will be a unique and exclusive brand of HWGB ...
February 06, 2020 07:00 ET | Source: Guardion Health Sciences, Inc.

Guardion® Announces Development of Unique Immuno-Supportive Complex Targeting Upper Respiratory Tract Infections

Formulation will be First Nutraceutical Compound to be Introduced Under Guardion’s Recently Acquired NutriGuard Business Line San Diego, California, Feb. 06, 2020 (GLOBE NEWSWIRE) --...